VIKING THERAPEUTICS, INC. (VKTX) Operating income 2016–2025
VIKING THERAPEUTICS, INC. (VKTX) annual operating income history from SEC filings — each fiscal year as reported.
-$393.3MFY2025 · since FY2016: -$13.8M → -$393.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$393.3M | -160.6% |
| FY2024 | -$150.9M | -49.7% |
| FY2023 | -$100.8M | -43.3% |
| FY2022 | -$70.4M | -26.4% |
| FY2021 | -$55.7M | -30.5% |
| FY2020 | -$42.7M | -30.5% |
| FY2019 | -$32.7M | -24.9% |
| FY2018 | -$26.2M | -37.2% |
| FY2017 | -$19.1M | -37.7% |
| FY2016 | -$13.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice